TradingView
RocketTickers
Nov 27, 2020 5:45 PM
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setm
Long
NASDAQ:RYTM
60
Rhythm Pharmaceuticals, Inc.
NASDAQ
Description
⋅
Nov 27, 2020 5:45 PM
RYTM: Rhythm Pharmaceuticals, Inc.
2020-11-27 07:30:00
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency
Beyond Technical Analysis
More